202
Participants
Start Date
December 31, 2013
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
pharmacologic treatment of the PDA
Following randomization, infants will be treated with medications used to produce PDA closure.
no pharmacologic treatment of the PDA
Following randomization, infants will NOT be treated with medications used to produce PDA closure (unless they develop rescue criteria at a later point in time).
NSAID
Indomethacin, ibuprofen or acetaminophen will be used as standard of care treatment
Columbia University, New York
Johns Hopkins University, Baltimore
South Miami Hospital, Miami
Mayo Clinic, Rochester
Northshore University Health System, Evanston
University of Chicago Medicine, Chicago
Sharp Mary Birch Hospital for Women and Newborns, San Diego
Mednax Neonatology of San Jose/Pediatrix Medical Group, San Jose
University of California San Francisco, San Francisco
Kaiser Permanente Santa Clara, Santa Clara
Providence St Vincent Medical Center, Portland
University of California San Diego, San Diego
Morristown Medical Center, Morristown
University Hospital, Umea, Sweden, Umeå
Ankara University School of Medicine Children's Hospital, Ankara
Sisli Hamidiye Etfal Training and Research Hospital, Istanbul
Inonu University School of Medicine Turgut Ozal Medical Center, Malatya
University of Glasgow, Royal Hospital for Sick Children, Glasgow
University of California, San Francisco
OTHER